WHO temporarily pauses hydroxychloroquine study due to safety concerns
Decision made after an observational study described how seriously ill Covid-19 patients treated with drug were more likely to die.
Gilead strikes deal to make remdesivir coronavirus treatment in 127 countries
![WHO on Monday, March 16, 2021 appealed to countries to keep vaccination campaigns going. [PHOTO | FILE]](https://k24.digital/wp-content/uploads/2020/04/VACCINE.jpg)
This month both the US and Japan authorised remdesivir as a treatment for Covid-19 patients.